The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638 · cited 1×
“In humans, anakinra combined with MTX has also been shown to provide significantly greater clinical benefit over MTX alon”
BackgroundGriffin, W. S. T., & Mrak, R. E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.233 · Cited by 248
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01063.x · Cited by 181
Cited by
Role of interleukin-1β during pain and inflammation
Ren, K., & Torres, R. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.020 · Cited by 717
Perry, M. M., Moschos, S. A., Williams, A. E., Shepherd, N. J., Larner-Svensson, H. M., & Lindsay, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5689 · Cited by 461
Lewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 443
The Interleukin 1β Pathway in the Pathogenesis of Osteoarthritis
DAHESHIA, M., & YAO, J. Q. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080346 · Cited by 421
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders
Barksby, H. E., Lea, S. R., Preshaw, P. M., & Taylor, J. J. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03441.x · Cited by 371
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 351
Unconventional Secretory Routes: Direct Protein Export Across the Plasma Membrane of Mammalian Cells
Nickel, W. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00302.x · Cited by 331
Miller, L. S., Pietras, E. M., Uricchio, L. H., Hirano, K., Rao, S., Lin, H., O’Connell, R. M., Iwakura, Y., Cheung, A. L., Cheng, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6933 · Cited by 325
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
Wannamaker, W., Davies, R., Namchuk, M., Pollard, J., Ford, P., Ku, G., Decker, C., Charifson, P., Weber, P., Germann, U. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111344 · Cited by 315
de Rivero Vaccari, J. P., Lotocki, G., Alonso, O. F., Bramlett, H. M., Dietrich, W. D., & Keane, R. W. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.46 · Cited by 312
Update on the biology of the chondrocyte and new approaches to treating cartilage diseases
Goldring, M. B. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.003 · Cited by 298
The role of the purinergic P2X7 receptor in inflammation
Lister, M. F., Sharkey, J., Sawatzky, D. A., Hodgkiss, J. P., Davidson, D. J., Rossi, A. G., & Finlayson, K. (2007) · Journal of Inflammation · doi:10.1186/1476-9255-4-5 · Cited by 253
Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224
“Current drugs approved for human use to modulate cytokine function are macromolecules [e.g., see [ 24 ,25]].”
Structural insights into the assembly and activation of IL-1β with its receptors
Wang, D., Zhang, S., Li, L., Liu, X., Mei, K., & Wang, X. (2010) · Nature Immunology · doi:10.1038/ni.1925 · Cited by 162
“Therefore, blocking IL-1β activity is of particular interest in clinical studies for treating such disease”
BackgroundTreatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
Osborn, O., Brownell, S. E., Sanchez-Alavez, M., Salomon, D., Gram, H., & Bartfai, T. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.004 · Cited by 160
Neuroimmune regulation of homeostatic synaptic plasticity
Pribiag, H., & Stellwagen, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.008 · Cited by 106
Catanzaro, J. M., Hueston, C. M., Deak, M. M., & Deak, T. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000072 · Cited by 27
“The synthesis and release of IL-1β has been linked to a variety of cellular consequences, including stress-related behavioral changes, sickness-like behaviors, and neuroendocrine sensitization (Dinarello, 2002; Johnson et al., 2002b, 2004, 2005; Braddock and Quinn, 2004).”
Background
Metadata
- Authors
- Braddock, M., & Quinn, A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-04-01
- Volume
- 3
- Issue
- 4
- Pages
- 330-340
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1984026160
- Cited by
- 214
- References
- 4
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.